Wikidata entity: Q66076148
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 186 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q142 (France) | France |
| P17 | country | ... | Q29 (Spain) | Spain |
| P17 | country | ... | Q38 (Italy) | Italy |
| P17 | country | ... | Q30 (United States) | United States |
| P17 | country | ... | Q145 (United Kingdom) | United Kingdom |
| P582 | end time | ... | 2019-05-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q124292 (cholangiocarcinoma) | cholangiocarcinoma |
| P6153 | research site | ... | Q49088 (Columbia University) | Columbia University |
| P6153 | research site | ... | Q126412 (Massachusetts General Hospital) | Massachusetts General Hospital |
| P6153 | research site | ... | Q170027 (University of London) | University of London |
| P6153 | research site | ... | Q4614 (University of Southern California) | University of Southern California |
| P6153 | research site | ... | Q193727 (Johns Hopkins University) | Johns Hopkins University |
| P6153 | research site | ... | Q219563 (University of Washington) | University of Washington |
| P6153 | research site | ... | Q230492 (University of Michigan) | University of Michigan |
| P6153 | research site | ... | Q1808012 (Memorial Sloan Kettering Cancer Center) | Memorial Sloan Kettering Cancer Center |
| P6153 | research site | ... | Q3803602 (Humanitas Research Hospital) | Humanitas Research Hospital |
| P6153 | research site | ... | Q4403855 (Seoul National University Hospital) | Seoul National University Hospital |
| P6153 | research site | ... | Q4803501 (Asan Medical Center) | Asan Medical Center |
| P6153 | research site | ... | Q5476635 (Fox Chase Cancer Center) | Fox Chase Cancer Center |
| P6153 | research site | ... | Q5902531 (Hospital Universitario 12 de Octubre) | Hospital Universitario 12 de Octubre |
| P6153 | research site | ... | Q7374195 (Royal Free London NHS Foundation Trust) | Royal Free London NHS Foundation Trust |
| P6153 | research site | ... | Q7896459 (University of Texas at Houston Police Department) | University of Texas at Houston Police Department |
| P6153 | research site | ... | Q7914455 (Vanderbilt University Medical Center) | Vanderbilt University Medical Center |
| P6153 | research site | ... | Q266227 (Institut Gustave Roussy) | Institut Gustave Roussy |
| P6153 | research site | ... | Q309350 (Northwestern University) | Northwestern University |
| P6153 | research site | ... | Q624119 (Samsung Medical Center) | Samsung Medical Center |
| P6153 | research site | ... | Q777403 (Washington University in St. Louis) | Washington University in St. Louis |
| P6153 | research site | ... | Q868421 (University of California, Irvine) | University of California, Irvine |
| P6153 | research site | ... | Q1061104 (University of California, San Francisco) | University of California, San Francisco |
| P6153 | research site | ... | Q1159198 (Dana–Farber Cancer Institute) | Dana–Farber Cancer Institute |
| P1813 | short name | Monolingualtext | ClarIDHy | ??? |
| P580 | start time | ... | 2017-01-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02989857 |
Why not click here or view trends?
log id: 3931505